Innovatus Life Sciences Acquisition Corp. (ILAC)

Innovatus Life Sciences Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Data will show when the stock starts trading.
Market Cap 224.60M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 22.46M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About ILAC

Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to initially focus our search on identifying a prospective target business in the life sciences sector. Our sponsor is an affiliate of Innovatus Capital Partners, LLC, a boutique private equity firm with 27 professionals focused on creating value in special situations, growth equity, emergin... [Read more...]

Industry Blank Check / SPAC
Founded 2021
CEO David Schiff
Country United States
Stock Exchange NASDAQ
Ticker Symbol ILAC
Full Company Profile


Innovatus Life Sciences Acquisition IPO Registration Document (S-1)

Innovatus Life Sciences Acquisition Corp. has filed to go public with an IPO on the NASDAQ.